Rajvir Dahiya

Rajvir Dahiya holds Ph.D. in Experimental Medicine from Post Graduate Institute of Medical Education and Research Chandigarh, India, post-doctoral fellowship in medical oncology research from the University of Chicago Pritzker School of Medicine, M.D. from the Kagoshima University Faculty of Medicine, Kagoshima, Japan and D.Sc. from the Osaka University Graduate School of Medicine, Osaka, Japan. He became director of Oncology Urology Oncology Research Center at the UCSF/VAMC in 1991. After 34 years of service, he retired as a Professor Emeritus and Director of Urology Research Center. Dahiya has published more than 550 original research manuscripts. Dahiya’s world ranking in medicine is 5690 (top 0.15%) and USA ranking is 3003 (top 1%) with more than 38,795 research citations and D-index of 108, i10-index of 325 in 2026. He has written books and holds multiple patents in oncology. Based on the NIH and VA data base NIH Reporter and Grantome, Dahiya's research programs were supported (99 times awarded) by the NIH and VA. Dahiya served for 25 years as a chairman and scientific reviewer for prostate, ovarian, and breast cancer research programs at the United States Department of Defense (DOD). In addition, he served as a scientific reviewer and chairman for nearly 30 years on numerous scientific committees and review panels for the NIH, including the National Cancer Institute (NCI) and the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). These roles involved evaluating nationally important medical research programs and supporting innovative biomedical research initiatives. Currently, he is an associate editor of “Clinical Cancer Research” journal.